ACTIVE

APOTEEK LEFEVER-FEYAERTS

Financial year 2025 · Closed on 31/12/2025

Net result6,8 k €+274,0 %over 1 year
Gross margin-2,7 k €+76,2 %over 1 year
Equity283,3 k €+2,5 %over 1 year

Identity

Source · BCE/KBO

APOTEEK LEFEVER-FEYAERTS is a Public limited company incorporated in 1997. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Overijse.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0460.761.183
Incorporation
30/05/1997
Legal form
Public limited company
Registered office
Brusselsesteenweg 225
3090 Overijse · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflow

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin-2,7 k €-11,3 k €80,8 k €136,3 k €135 k €
EBITDA-3,1 k €-11,7 k €-15,8 k €56,2 k €60,3 k €
Operating result-3,1 k €-11,7 k €-15,8 k €56,2 k €58,5 k €
Net result6,8 k €-3,9 k €-14,1 k €42,9 k €49,6 k €
Balance sheet
Equity283,3 k €276,5 k €280,4 k €294,6 k €251,7 k €
Total assets283,6 k €277,9 k €336,2 k €371,4 k €322,4 k €
Cash27,9 k €31 k €208,3 k €177,9 k €135,8 k €
Debts316 €1,4 k €52,3 k €76,8 k €70,2 k €
Other
Workforce–0,0 ETP–––

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 19 ended

Active mandates

APOTHEEK BARBIER - DENEYER

Director · since 01 janvier 2024 · 0426.594.122

Represented by Barbier LUC

Active
BENEPHARMA

Director · since 01 janvier 2024 · 0685.992.809

Represented by Vermeulen BENEDICTE

Active
Farmacenter

Director · since 01 janvier 2024 · 0716.974.906

Represented by Maisin MARIE-ANNE EN STRYBOL KAAT

Active
VALAPHARMA

Director · since 01 janvier 2024 · 0862.841.229

Represented by Levie VALÉRIE

Active

Ended mandates

APOTHEEK BARBIER - DENEYER

Director · since 01 janvier 2024 · 0426.594.122

Represented by Barbier LUC

Ended
BENEPHARMA

Director · since 01 janvier 2024 · 0685.992.809

Represented by Vermeulen BENEDICTE

Ended
Farmacenter

Director · since 01 janvier 2024 · 0716.974.906

Represented by Maisin MARIE-ANNE

Ended
VALAPHARMA

Director · since 01 janvier 2024 · 0862.841.229

Represented by Levie VALÉRIE

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/07/202623/07/202530/07/202411/07/202328/07/202230/07/2021
General meeting27/05/202628/05/202530/04/202414/06/202330/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202527/05/202616/07/2026DutchPDF
Abridged model31/12/202428/05/202523/07/2025DutchPDF
Micro model31/12/202330/04/202430/07/2024DutchPDF
Micro model31/12/202214/06/202311/07/2023DutchPDF
Micro model31/12/202130/06/202228/07/2022DutchPDF
Micro model31/12/202030/06/202130/07/2021DutchPDF
Micro model31/12/201930/06/202030/07/2020DutchPDF
Micro model31/12/201830/06/201916/07/2019DutchPDF
Micro model31/12/201723/05/201830/07/2018DutchPDF
Abridged model31/12/201630/06/201726/07/2017DutchPDF
Abridged model31/12/201515/06/201628/06/2016DutchPDF
Abridged model31/12/201427/05/201528/07/2015DutchPDF
Abridged model31/12/201317/06/201411/07/2014DutchPDF
Abridged model31/12/201222/05/201329/05/2013DutchPDF
Abridged model31/12/201123/05/201206/06/2012DutchPDF
Abridged model31/12/201025/05/201127/05/2011DutchPDF
Abridged model31/12/200926/05/201001/06/2010DutchPDF
Abridged model31/12/200827/05/200926/06/2009DutchPDF
Abridged model31/12/200728/05/200825/06/2008DutchPDF
Abridged model31/12/200623/05/200707/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 19 ended

Active mandates

APOTHEEK BARBIER - DENEYER

Director · since 01 janvier 2024 · 0426.594.122

Represented by Barbier LUC

Active
BENEPHARMA

Director · since 01 janvier 2024 · 0685.992.809

Represented by Vermeulen BENEDICTE

Active
Farmacenter

Director · since 01 janvier 2024 · 0716.974.906

Represented by Maisin MARIE-ANNE EN STRYBOL KAAT

Active
VALAPHARMA

Director · since 01 janvier 2024 · 0862.841.229

Represented by Levie VALÉRIE

Active

Ended mandates

APOTHEEK BARBIER - DENEYER

Director · since 01 janvier 2024 · 0426.594.122

Represented by Barbier LUC

Ended
BENEPHARMA

Director · since 01 janvier 2024 · 0685.992.809

Represented by Vermeulen BENEDICTE

Ended
Farmacenter

Director · since 01 janvier 2024 · 0716.974.906

Represented by Maisin MARIE-ANNE

Ended
VALAPHARMA

Director · since 01 janvier 2024 · 0862.841.229

Represented by Levie VALÉRIE

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates08/04/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates12/02/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/08/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/06/2011
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates09/12/2005
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20256,8 k €↑
  2. 2024
    Annual accounts 2024-3,9 k €↑
  3. 2023
    Annual accounts 2023-14,1 k €↓
  4. 2022
    Annual accounts 202242,9 k €↓
  5. 2021
    Annual accounts 202149,6 k €↑
  6. 2019
    Annual accounts 2019-6,6 k €↓
  7. 2018
    Annual accounts 201810,2 k €↑
  8. 2017
    Annual accounts 20173,8 k €↓
  9. 2016
    Annual accounts 201646,5 k €↑
  10. 2015
    Annual accounts 201522,2 k €↓
  11. 2014
    Annual accounts 201427,2 k €↓
  12. 2013
    Annual accounts 201359,9 k €↑
  13. 2012
    Annual accounts 2012-42,9 k €↓
  14. 2011
    Annual accounts 201124,3 k €↓
  15. 2010
    Annual accounts 201030,7 k €↓
  16. 2009
    Annual accounts 200931 k €↑
  17. 2008
    Annual accounts 200827,3 k €↓
  18. 2007
    Annual accounts 200788,6 k €↑
  19. 2006
    Annual accounts 200631,6 k €
  20. 30/05/1997
    IncorporationPublic limited company